Actively Recruiting
Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
Led by Chinese PLA General Hospital · Updated on 2023-06-22
750
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational, multicenter, parallel control study, planning to enroll 750 eligible patients to receive automated peritoneal dialysis with remote patient management (APD-RPM) and continuous ambulatory peritoneal dialysis (CAPD). Patients will attend follow-up every 12 ± 1 weeks for a total of 156 weeks. This study aims to compare the effects of APD-RPM and CAPD treatment on the prognosis and quality of life.
CONDITIONS
Official Title
Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years to 75 years
- Confirmed diagnosis of end-stage renal disease
- Rapid peritoneal solute transfer rate shown by 4-hour D/P creatinine value greater than 0.65
- Able to comply with standard peritoneal dialysis treatment at home
- On peritoneal dialysis for 3 months or longer
- Fully understand the study and have signed informed consent
You will not qualify if you...
- Preparing for kidney transplantation within 3 years
- Need combined hemodialysis treatment
- Allergic to components of peritoneal dialysis fluid
- Severe cardio-cerebrovascular diseases, including congestive heart failure grade III or above, recent heart attack or stroke, malignant arrhythmia needing treatment, dilated cardiomyopathy
- Serious liver diseases such as cirrhosis or acute liver injury with ALT or AST twice the normal level
- Active or treated malignant tumors, HIV infection
- Pregnant or breastfeeding women who do not agree to use effective contraceptives during the trial
- History of alcohol or illegal drug abuse
- Unable to continue CAPD due to ultrafiltration failure
- Mental retardation or mental illness
- Use of icodextrin dialysate
- Participation in other clinical trials in past 3 months
- Peritonitis in past 3 months
- Other conditions as decided by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853
Actively Recruiting
Research Team
X
Xiangmei Chen
CONTACT
J
Jianhui Zhou
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here